SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mickaël Hiligsmann, Silvia M. Evers, Wafa Ben Sedrine, John A. Kanis, Bram Ramaekers, Jean-Yves Reginster, Stuart Silverman, Caroline E. Wyers, Annelies Boonen, A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis, PharmacoEconomics, 2014,

    CrossRef

  2. 2
    K. Kim, A. Svedbom, X. Luo, S. Sutradhar, J. A. Kanis, Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm, Osteoporosis International, 2014, 25, 1, 325

    CrossRef

  3. 3
    M. Hiligsmann, W. Ben Sedrine, O. Bruyere, S. M. Evers, V. Rabenda, J.-Y. Reginster, Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis, The European Journal of Public Health, 2014,

    CrossRef

  4. 4
    Jean-Yves Reginster, Serge Ferrari, Peyman Hadji, Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifene, Current Medical Research and Opinion, 2014, 30, 6, 1165

    CrossRef

  5. 5
    Nicolás Mendoza, Rafael Sánchez-Borrego, José Villero, Francesc Baró, Joaquim Calaf, Ma Jesús Cancelo, Pluvio Coronado, Antonio Estévez, Jose M. Fernández-Moya, Silvia González, Plácido Llaneza, Jose Luis Neyro, Javier del Pino, Esteban Rodríguez, Elena Ruiz, Antonio Cano, 2013 Up-date of the consensus statement of the Spanish Menopause Society on postmenopausal osteoporosis, Maturitas, 2013, 76, 1, 99

    CrossRef